TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15918622

Group type: EXPERIMENTAL
Intervention: Long acting octreotide (100 mcg subcutaneously thrice daily for two weeks, then 20 mg intramuscularly monthly)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Long acting octreotide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (20 patients who refused treatment)
Number of subjects: 22
Study: 12558577

Group type: EXPERIMENTAL
Intervention: Sulthiame (STM) monotherapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 10570723

Group type: EXPERIMENTAL
Intervention: Migraine with aura (n = 6)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Migraine without aura (n = 13)
Number of subjects: 28
Study: 9417493

Group type: EXPERIMENTAL
Intervention: Sodium-selenit 200 micrograms/d
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 8383150

Group type: EXPERIMENTAL
Intervention: Bacteriostatic saline solution with 1% lidocaine with epinephrine 1:300,000
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1% lidocaine with epinephrine 1:100,000 with sodium bicarbonate 80 meq/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bacteriostatic saline solution with 1% lidocaine with epinephrine 1:100,000
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% lidocaine with epinephrine 1:100,000
Number of subjects: 0
Study: 3017392

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate, 2 g, administered 6 hourly for three doses daily beginning 1 day before DEC was started and continued throughout the DEC therapy.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no bicarbonate treatment).
Number of subjects: 21
Study: 29773717

Group type: EXPERIMENTAL
Intervention: PD-1 inhibitors (nivolumab)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: STK11/LKB1 alterations
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Stk11/Lkb1 loss in murine models
Number of subjects: 174
Study: 27416024

Group type: EXPERIMENTAL
Intervention: Corticosteroids (CS)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Corticosteroids plus azathioprine (CS+A)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 325
Study: 24906602

Group type: EXPERIMENTAL
Intervention: Digital drainage systems
Number of subjects: 381
Study: 23238355

Group type: EXPERIMENTAL
Intervention: 400 mg racemic ibuprofen suppository
Number of subjects: 10

Group type: COMPARATOR
Intervention: 400 mg ibuprofen syrup
Number of subjects: 10
Study: 20479446

Group type: EXPERIMENTAL
Intervention: 870- and 930-nm light exposure treatment
Number of subjects: 26
Study: 18303470

Group type: EXPERIMENTAL
Intervention: Leg extension power (LEP) of the fractured leg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Leg extension power (LEP) of the nonfractured leg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Asymmetrical LEP deficit
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: LEP of the nonfractured leg at week 1
Number of subjects: 43
Study: 16323028

Group type: EXPERIMENTAL
Intervention: Lipid-based nasal ointment
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (non-use of the test agent)
Number of subjects: 33
Study: 12220761

Group type: COMPARATOR
Intervention: Fluoxetine 20 mg
Number of subjects: 260

Group type: COMPARATOR
Intervention: Fluoxetine 10 mg
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 260
Study: 10414911

Group type: EXPERIMENTAL
Intervention: G-CSF (5 microg/kg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: GM-CSF (500 microg/day)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: G-CSF and GM-CSF
Number of subjects: 46
Study: 8600199

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for symptomatic bacteriuria
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment or placebo (Control)
Number of subjects: 50
Study: 8358504

Group type: EXPERIMENTAL
Intervention: THA + lecithin
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: THA + placebo
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo + placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: THA treatment
Number of subjects: 17
Study: 3781699

Group type: EXPERIMENTAL
Intervention: Minocycline + gentamicin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Metronidazole + gentamicin
Number of subjects: 70
Study: 29551430

Group type: EXPERIMENTAL
Intervention: GnRHa plus add-back (Leuprolide depot 11.25 mg intramuscular injection every 3 months, plus oral norethindrone acetate 5 mg daily)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: GnRHa plus modified 2-drug add-back regimen (oral norethindrone acetate 5 mg daily and oral conjugated equine estrogens 0.625 mg daily)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: GnRHa plus add-back
Number of subjects: 51
Study: 29282929

Group type: EXPERIMENTAL
Intervention: Intravenous drip group (group A)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Topical application group (group B)
Number of subjects: 68
Study: 24462480

Group type: EXPERIMENTAL
Intervention: Combined intervention (parent-student intervention)
Number of subjects: 3490

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3490
Study: 23043083

Group type: EXPERIMENTAL
Intervention: Chlorhexidine dressings
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Highly adhesive dressings
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Nonchlorhexidine dressings
Number of subjects: 1879
Study: 20875374

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 100 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 150 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 18550935

Group type: EXPERIMENTAL
Intervention: Valsartan/HCTZ (160/12.5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HCTZ (25 mg)
Number of subjects: 0
Study: 15345500

Group type: EXPERIMENTAL
Intervention: AZD3582 750 mg twice daily
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: naproxen 500 mg twice daily
Number of subjects: 970

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 970
Study: 12354470

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nitric oxide (10-20 ppm)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Epoprostenol (mean 8.0 ng/kg per min)
Number of subjects: 16
Study: 10748772

Group type: EXPERIMENTAL
Intervention: Pethidine 1 mg/kg i.v. 5 minutes before induction of anaesthesia (before skin incision)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pethidine administered intraoperatively
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Postoperative analgesic requirements
Number of subjects: 30
Study: 8768686

Group type: EXPERIMENTAL
Intervention: Taped music and a message from their physicians during the next four chemotherapy treatments (n = 47)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No intervention (control group, n = 50)
Number of subjects: 97
Study: 1673587

Group type: EXPERIMENTAL
Intervention: Intravenous xamoterol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral xamoterol, 200 mg twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral xamoterol
Number of subjects: 30
Study: 7232091

Group type: EXPERIMENTAL
Intervention: Feingold diet violations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noninfraction conditions
Number of subjects: 0
Study: 30801699

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 101

Group type: COMPARATOR
Intervention: High-dose adrenocorticotropic hormone (ACTH)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) without prior vigabatrin (VGB)
Number of subjects: 101

Group type: COMPARATOR
Intervention: High-dose adrenocorticotropic hormone (ACTH) without prior vigabatrin (VGB)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) with prior vigabatrin (VGB)
Number of subjects: 101

Group type: COMPARATOR
Intervention: High-dose adrenocorticotropic hormone (ACTH) with prior vigabatrin (VGB)
Number of subjects: 101
Study: 27364900

Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg IR/ER every 12 hours
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard ibuprofen 200 mg IR every 4 hours
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg IR/ER with food
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Multiple doses of ibuprofen IR/ER
Number of subjects: 63
Study: 25070347

Group type: EXPERIMENTAL
Intervention: Aliskiren (300mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Valsartan (320mg)
Number of subjects: 32
Study: 23662746

Group type: EXPERIMENTAL
Intervention: Provider counseling with supplemental group education (n=112)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Individual provider counseling (n=331)
Number of subjects: 443
Study: 21289620

Group type: EXPERIMENTAL
Intervention: 5 mg oral synthetic THC
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 15 mg oral synthetic THC
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low dose Sativex (5.4 mg THC, 5.0 mg CBD)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High dose Sativex (16.2 mg THC, 15.0 mg CBD)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 19169946

Group type: EXPERIMENTAL
Intervention: Rice noodles
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Long-grain rice
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Easy-cook long-grain rice
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: White basmati rice
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Other rice types (white basmati, brown basmati, easy-cook basmati, basmati and wild rice, Thai red rice, Thai glutinous rice)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucose standard
Number of subjects: 14
Study: 17665810

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for depressed adolescents (IPT-A)
Number of subjects: 0
Study: 15066470

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0
Study: 11480801

Group type: EXPERIMENTAL
Intervention: Capping punitive damages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No option to award punitive damages
Number of subjects: 0
Study: 9554429

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 7825744

Group type: EXPERIMENTAL
Intervention: Luminol‐dependent chemiluminescence (CL) in semen of infertile men
Number of subjects: 49
Study: 3240842

Group type: EXPERIMENTAL
Intervention: 10% protein diet (0.9 +/- 0.06 g.kg‐1.day‐1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 20% protein diet (1.9 +/- 0.1 g.kg‐1.day‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low protein diet
Number of subjects: 16
Study: 30273290

Group type: EXPERIMENTAL
Intervention: Lower-body fatigue
Number of subjects: 24
Study: 29803539

Group type: EXPERIMENTAL
Intervention: Standard care plus illustrated information (pictograms and simple text)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 116
Study: 29330997

Group type: EXPERIMENTAL
Intervention: Various Vitamin D3 preparations (Cholecalciferol) administered orally and intramuscularly
Number of subjects: 320
Study: 25077885

Group type: EXPERIMENTAL
Intervention: Inositol
Number of subjects: 0
Study: 23746561

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0
Study: 21908159

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 93
Study: 18216316

Group type: EXPERIMENTAL
Intervention: Ferric gluconate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no ferric gluconate)
Number of subjects: 0
Study: 17023868

Group type: EXPERIMENTAL
Intervention: Methylphenidate at titrated doses (average, 14.2 mg/day) administered three times daily, 7 days/week for approximately 1 year
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment for 95 children who remained on medication
Number of subjects: 140
Study: 12717397

Group type: EXPERIMENTAL
Intervention: Synbiotic regimen
Number of subjects: 36

Group type: COMPARATOR
Intervention: Endotoxin stimulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cirrhosis (baseline)
Number of subjects: 36
Study: 10886792

Group type: EXPERIMENTAL
Intervention: Branded sodium stibogluconate (Pentostam)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Generic sodium stibogluconate (Albert David Ltd)
Number of subjects: 516
Study: 8813840

Group type: EXPERIMENTAL
Intervention: Physical training (20 min/day, 5 days/week bicycle exercise)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Detraining
Number of subjects: 12
Study: 1566165

Group type: EXPERIMENTAL
Intervention: High-intensity trunk exercise program (3 sets of 10 repetitions for sit-up, prone trunk extension, and double leg flexion exercises, performed a minimum of three times per week for 1 year)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 3929320

Group type: EXPERIMENTAL
Intervention: Chronic lithium treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other psychoactive drugs (not specified)
Number of subjects: 0
Study: 30804029

Group type: EXPERIMENTAL
Intervention: Gamified Curriculum Group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional Curriculum Group
Number of subjects: 36
Study: 29198730

Group type: EXPERIMENTAL
Intervention: Narrative intervention
Number of subjects: 2655

Group type: COMPARATOR
Intervention: Didactic intervention
Number of subjects: 2655
Study: 27103421

Group type: EXPERIMENTAL
Intervention: Intervention delivered by trained psychosocial workers via telephone, based on Motivational Interviewing principles
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Intervention sessions
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Fidelity and acceptability of the intervention
Number of subjects: 144
Study: 24859868

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous aerobic exercise intervention for 12 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stretching control for 12 months
Number of subjects: 100
Study: 22978101

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) therapy
Number of subjects: 91

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: CM + chemotherapy
Number of subjects: 91
Study: 20466596

Group type: EXPERIMENTAL
Intervention: Behavioral interventions (specific types not detailed)
Number of subjects: 0
Study: 17435518

Group type: EXPERIMENTAL
Intervention: Menicon Z (MenZ; Dk/t = 91)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Equalens II (EqII; Dk/t = 47)
Number of subjects: 20
Study: 15996258

Group type: EXPERIMENTAL
Intervention: Split liver transplantation (SLT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Willingness to share organs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Priority for pediatric candidates
Number of subjects: 50
Study: 12559281

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 1095

Group type: EXPERIMENTAL
Intervention: Doxazosin plus finasteride
Number of subjects: 1095

Group type: COMPARATOR
Intervention: Finasteride
Number of subjects: 1095

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1095
Study: 10233188

Group type: EXPERIMENTAL
Intervention: OAM = omeprazole 20 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: RAM = ranitidine 300 mg b.d. + amoxycillin 1 g b.d. + metronidazole 500 mg b.d.
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: OAC = omeprazole 20 mg b.d. + amoxycillin 1 g b.d. + clarithromycin 250 mg t.d.s.
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: RAC = ranitidine 300 mg b.d. + amoxycillin 1 g b.d. + clarithromycin 250 mg t.d.s.
Number of subjects: 320
Study: 8904327

Group type: EXPERIMENTAL
Intervention: 5 g EACA upon initiation of cardiopulmonary bypass (CPB)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No antifibrinolytic drugs prior to CPB
Number of subjects: 46
Study: 1885077

Group type: EXPERIMENTAL
Intervention: Cycling on a bicycle ergometer for 1 hour every day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Jogging on a treadmill for 1 hour every day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Resting in a chair for 1 hour every day
Number of subjects: 10
Study: 6864291

Group type: EXPERIMENTAL
Intervention: Discectomy without fusion (DE)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Discectomy with fusion (DEF)
Number of subjects: 63
Study: 31665037

Group type: EXPERIMENTAL
Intervention: Women's primary education
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Secondary (9+) education
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Husband's primary education
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Husband's secondary (9+) education
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Knowledge about RHR
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Marriage duration of more than 10 years
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Access to micro‐credit enterprises
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Having gender equitable attitude
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Good qualities of spousal relation
Number of subjects: 415
Study: 30571418

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: DOACs (various)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 70

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 70
Study: 27002280

Group type: EXPERIMENTAL
Intervention: PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: EC-ASA (enteric-coated aspirin 325 mg)
Number of subjects: 0
Study: 24385131

Group type: EXPERIMENTAL
Intervention: Very low doses of ethanol (<5 mM blood concentration)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1 mg of alprazolam
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 10 mg of zolpidem
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 22179861

Group type: COMPARATOR
Intervention: Celecoxib (NSAID)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Oxycodone (Opioid)
Number of subjects: 6
Study: 20122176

Group type: EXPERIMENTAL
Intervention: Educational programme including peer discussions, with eight pages of written material and a two-hour face-to-face discussion session.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Educational programme including peer discussions.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no educational programme).
Number of subjects: 74
Study: 17071932

Group type: EXPERIMENTAL
Intervention: Extended-field radiotherapy (EF-RT) 30 Gy + 10 Gy to bulky disease
Number of subjects: 1064

Group type: COMPARATOR
Intervention: Involved-field radiotherapy (IF-RT) 30 Gy + 10 Gy to bulky disease
Number of subjects: 1064
Study: 14693590

Group type: EXPERIMENTAL
Intervention: 40 mg 2% preservative-free 2-chloroprocaine
Number of subjects: 8

Group type: COMPARATOR
Intervention: 40 mg 2% lidocaine
Number of subjects: 8
Study: 12378742

Group type: EXPERIMENTAL
Intervention: Atovaquone + proguanil combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atovaquone + proguanil prophylaxis
Number of subjects: 0
Study: 9828793

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EUA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TRU
Number of subjects: 60
Study: 10171932

Group type: EXPERIMENTAL
Intervention: ComputerLink project intervention providing information and support to caregivers
Number of subjects: 0
Study: 2547950

Group type: EXPERIMENTAL
Intervention: Enalapril (10 to 40 mg daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (25 to 100 mg daily)
Number of subjects: 32
Study: 327854

Group type: EXPERIMENTAL
Intervention: Droperidol (5 mg)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Hydroxyzine HCl (50 mg)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 280
Study: 31788318

Group type: EXPERIMENTAL
Intervention: Dotinurad (0.5-20 mg single-dose administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PK/PD model predictions
Number of subjects: 0
Study: 26480553

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding therapy applied to Qugu (CV 2), Shenshu (BL 23), Zhibian (BL 54), Huiyin (CV 1) and Sanyinjiao (SP 6), once every two weeks for 4 weeks, with two sessions total.
Number of subjects: 180

Group type: COMPARATOR
Intervention: Western medication group: tamsulosin capsules 0.2 mg once daily and indometacin sustained release tablets 25 mg three times daily for 8 weeks.
Number of subjects: 180
Study: 23890958

Group type: EXPERIMENTAL
Intervention: Urban Circuits Group (UCG)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Usual Care Group (NCG)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control Group (not enrolled in rehabilitation program)
Number of subjects: 83
Study: 21457390

Group type: EXPERIMENTAL
Intervention: Sterile gloves
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clean, nonsterile gloves
Number of subjects: 60

Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 60
Study: 18841390

Group type: EXPERIMENTAL
Intervention: Parallel processing of two tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate degree of parallel processing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serial processing of two tasks
Number of subjects: 0
Study: 16202481

Group type: EXPERIMENTAL
Intervention: Scopolamine 0.3 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 15279041

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 227

Group type: COMPARATOR
Intervention: Usual care with first generation agents
Number of subjects: 227